[1] GhavidelAA,JalilifarN,SharifiM,GhasemzadehB,AlinejadZ,GhafarinejadMH,KhamushiA,,2009,Role of epsilon aminocaproic acid & tranexamic acid, vsplacebo in reduction of mediastinal bleeding following open heart surgery,Iranian J Card Surg,2,13,7
[2] SantosAT,KalilRA,BauemannC,PereiraJB,NesrallaIA,,2006,A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting,Braz J Med Biol Res,39,63,9
[3] LemmerJHJr,StanfordW,BonneySL,BreenJF,ChomkaEV,,1994,Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency: Amulticenter, randomized, double blind, placebo-controlled study,J Thorac Cardiovasc Surg,107,543,53
[4] FawzyH,ElmistekawyE,BonneauD,LatterD,,,Can local 5,,,,
[5] ,2009,application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trail,J Cardiothorac Surg,4,25,
[6] DunnCJ,GoaKL,,1999,Tranexamic acid: A review of its use in surgery and other indications,Drugs,57,1005,32
[7] HardyJF,DesrochesJ,,1992,Natural and synthetic antifibrinolytics in cardiac surgery,Can J Anesth,39,353,65
[8] BaricD,BiocinaB,UnicD,SutlicZ,RudezI,BacicVV,,2007,Topical use of antifibrinolytic agents reduce postoperative bleeding: A double-blind, prospective, randomized study,Eur J Cardiothorac Surg,31,366,71
[9] Valsecchi A,,1980,Further notes on the topical use of tranexamic acid in the treatment of gynaecological hemorrhage,Minerva Ginecol,32,825,30
[10] Sindet-PedersenS,RamstromG,BernvilS,,1989,Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery,N Engl J Med,320,840,3
[11] FergussonDA,MazerCD,FremesS,MacAdamsC,,2008,A comparison of aprotinin and lysine analogues in high-risk cardiac surgery,N Engl J Med,358,2319,31
[12] ,,Haemic (Tranexamic acid) antiplasmin action [image on internet] [Online],2015 [Cited 2016 August,7,,
[13] TatarH,CiçekS,DemirkiliçU,OzalE,SüerH,,1993,Topical use of aprotinin in open heart operations,Ann Thorac Surg,55,659,61
[14] O'ReganDJ,GiannopoulosN,MedirattaN,KendallSW,ForniA,PillaiR,,1994,Topical aprotinin in cardiac operations,Ann Thorac Surg,58,778,81
[15] ThrombHaemost,,2004,,,92,568,74
[16] De BonisM,CavaliereF,AlessandriniF,LapennaE,SantarelliF,MoscatoU,,2000,Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study,J Thorac Cardiovasc Surg,119,575,80
[17] Abul-AzmA,AbdullahKM,,2006,Effect of topicaltranexamic acid in open heart surgery,Eur J Anaesthesiol,23,380,4
[18] YasimA,AsikR,AtahanE.,,2005,Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery,Anadolu Kardiyol Derg,5,36,40
[19] Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, et al.
Fibrinolytics inhibitors in off-pump coronary surgery: a prospective,
randomized, double-blind TAP study (tranexamic acid, aprotonin,
placebo). Eur J Cardiothorac Surg 2005; 28: 563-8.
[20] MonganPD,BrownRS,ThwaitesBK,,1998,Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization,Anesth Analg,87,258,65
[21] CasatiV,GuzzonD,OppizziM,TorriG,CaloriG,,2000,Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions,J Thorac Cardiovasc Surg,120,520,7